BioCentury | Oct 10, 2005
Company News

Rejuvenon metabolic, cancer news

...Rejuvenon changed its name to Sapphire Therapeutics Inc. Rejuvenon Corp. , Bridgewater, N.J. Business: Metabolic, Cancer WIR Staff cancer...
BioCentury | Jul 25, 2005
Clinical News

RC-1291: Phase II started

...<100 patients. RC-1291 has Fast Track designation to treat cachexia and anorexia in cancer patients. Rejuvenon Corp....
BioCentury | Jul 25, 2005
Clinical News

RC-8800: Phase I started

...Rejuvenon began a dose-escalation, U.S. Phase I trial in 8 to 12 healthy subjects. Rejuvenon Corp....
BioCentury | May 9, 2005
Product Development

Plucking from pharma

...stock, and BMY can receive milestones and royalties. Another company pursuing a similar product is Rejuvenon Corp....
BioCentury | Jan 10, 2005
Clinical News

RC-1291: Fast Track designation received

...to RC-1291, a small molecule ghrelin mimetic, to treat cachexia and anorexia in cancer patients. Rejuvenon Corp....
BioCentury | Nov 8, 2004
Company News

Rejuvenon management update

Rejuvenon Corp. , The Woodlands, Texas Business: Metabolic, Cancer Hired: Gary Cupit as president and CEO, previously VP and head of search and evaluation for Novartis AG ; he replaces Peter Policastro, who is departing WIR...
BioCentury | Jun 28, 2004
Finance

Ebb & Flow

...are managers. GLFD closed Friday at $4.69, down $0.66 (10%) on the week. Private rounds Rejuvenon...
BioCentury | Jun 28, 2004
Company News

Rejuvenon board of directors update

Rejuvenon Corp. , The Woodlands, Texas Business: Metabolic, Cancer Appointed: Lutz Giebel, venture partner at Schroder Ventures Life Sciences; Robert Mashal, partner at Boston Millennia Partners; and Carl Gordon, general partner at OrbiMed Advisors WIR Staff...
BioCentury | Jun 23, 2004
Financial News

Rejuvenon raises $37 million

...Texas) raised $37 million in a series B round led by Schroder Ventures Life Sciences. Rejuvenon...
...Mashal, a partner at Boston Millennia; and Carl Gordon, general partner at OrbiMed, will join Rejuvenon's...
BioCentury | May 20, 2002
Company News

Rejuvenon management update

Rejuvenon Corp. , Houston, Texas Business: Metabolic, Musculoskeletal Hired: William Polvino as SVP of clinical development, formerly VP of clinical affairs and acting head of development at Theravance Inc. WIR Staff...
Items per page:
1 - 10 of 15
BioCentury | Oct 10, 2005
Company News

Rejuvenon metabolic, cancer news

...Rejuvenon changed its name to Sapphire Therapeutics Inc. Rejuvenon Corp. , Bridgewater, N.J. Business: Metabolic, Cancer WIR Staff cancer...
BioCentury | Jul 25, 2005
Clinical News

RC-1291: Phase II started

...<100 patients. RC-1291 has Fast Track designation to treat cachexia and anorexia in cancer patients. Rejuvenon Corp....
BioCentury | Jul 25, 2005
Clinical News

RC-8800: Phase I started

...Rejuvenon began a dose-escalation, U.S. Phase I trial in 8 to 12 healthy subjects. Rejuvenon Corp....
BioCentury | May 9, 2005
Product Development

Plucking from pharma

...stock, and BMY can receive milestones and royalties. Another company pursuing a similar product is Rejuvenon Corp....
BioCentury | Jan 10, 2005
Clinical News

RC-1291: Fast Track designation received

...to RC-1291, a small molecule ghrelin mimetic, to treat cachexia and anorexia in cancer patients. Rejuvenon Corp....
BioCentury | Nov 8, 2004
Company News

Rejuvenon management update

Rejuvenon Corp. , The Woodlands, Texas Business: Metabolic, Cancer Hired: Gary Cupit as president and CEO, previously VP and head of search and evaluation for Novartis AG ; he replaces Peter Policastro, who is departing WIR...
BioCentury | Jun 28, 2004
Finance

Ebb & Flow

...are managers. GLFD closed Friday at $4.69, down $0.66 (10%) on the week. Private rounds Rejuvenon...
BioCentury | Jun 28, 2004
Company News

Rejuvenon board of directors update

Rejuvenon Corp. , The Woodlands, Texas Business: Metabolic, Cancer Appointed: Lutz Giebel, venture partner at Schroder Ventures Life Sciences; Robert Mashal, partner at Boston Millennia Partners; and Carl Gordon, general partner at OrbiMed Advisors WIR Staff...
BioCentury | Jun 23, 2004
Financial News

Rejuvenon raises $37 million

...Texas) raised $37 million in a series B round led by Schroder Ventures Life Sciences. Rejuvenon...
...Mashal, a partner at Boston Millennia; and Carl Gordon, general partner at OrbiMed, will join Rejuvenon's...
BioCentury | May 20, 2002
Company News

Rejuvenon management update

Rejuvenon Corp. , Houston, Texas Business: Metabolic, Musculoskeletal Hired: William Polvino as SVP of clinical development, formerly VP of clinical affairs and acting head of development at Theravance Inc. WIR Staff...
Items per page:
1 - 10 of 15